(NASDAQ: IVF) Invo Fertility's forecast annual revenue growth rate of 48.48% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.46%.
Invo Fertility's revenue in 2026 is $6,943,899.On average, 2 Wall Street analysts forecast IVF's revenue for 2026 to be $19,901,992, with the lowest IVF revenue forecast at $19,311,911, and the highest IVF revenue forecast at $20,690,658. On average, 2 Wall Street analysts forecast IVF's revenue for 2027 to be $31,444,504, with the lowest IVF revenue forecast at $30,510,210, and the highest IVF revenue forecast at $32,688,970.
In 2028, IVF is forecast to generate $17,747,818 in revenue, with the lowest revenue forecast at $17,220,150 and the highest revenue forecast at $18,451,376.